Copy Link Print Information

Besufetamig

(Synonyms: ONO-4685)
Kundenbewertung

Based on 1 Customer Validation

Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.98%
  • CAS. Nr.: 3037124-22-1
  • Molecular Weight:146.01 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Besufetamig
  • Experimental Validation Results for Besufetamig
  • Experimental Validation Results for Besufetamig
  • Experimental Validation Results for Besufetamig
  • Experimental Validation Results for Besufetamig
  • Besufetamig Chemical Structure
    Besufetamig Chemical Structure
CAS. Nr.: 3037124-22-1
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Besufetamig Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa

  • 1/16

    Immobilized PD-1 Protein, Human (143a.a, HEK293, His, HY-P7396) can bind Besufetamig. The EC50 for this effect is 5.266 ng/mL.

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Besufetamig. The EC50 for this effect is 41.78 ng/mL.

  • 1/16

    Flow Cytometry analysis of Hela cells labelling PD-1 (red) with Besufetamig (anti-PD-1) (HY-P991122, red). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99991, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Flow Cytometry analysis of Jurkat cells labelling CD3E (red) with Besufetamig (anti-CD3E) (HY-P991122, red). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99991, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Besufetamig Chemical Structure
    1/16
  • Besufetamig
  • Immobilized PD-1 Protein, Human (143a.a, HEK293, His, HY-P7396) can bind Besufetamig. The EC50 for this effect is 5.266 ng/mL.
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Besufetamig. The EC50 for this effect is 41.78 ng/mL.
  • Flow Cytometry analysis of Hela cells labelling PD-1 (red) with Besufetamig (anti-PD-1) (HY-P991122, red). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99991, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Flow Cytometry analysis of Jurkat cells labelling CD3E (red) with Besufetamig (anti-CD3E) (HY-P991122, red). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99991, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • IgG1-kappa